TY - JOUR JO - EuroIntervention TI - Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial AB - <p class="text-1er-paragraph" xml:lang='en-gb'><span class="appel-table-et-figure">Aims:</span> Patients with diabetes mellitus have increased risk of in-stent restenosis after coronary stent implantation due to neointimal hyperplasia (NIH). The aim of th AU - Jensen Okkels Lisette AU - Maeng Michael AU - Thayssen Per AU - Villadsen Anton B. AU - Krusell Lars Romer AU - Bøtker Erik Hans AU - Pedersen Knud AU - Aaroe Jens AU - Christiansen Høj Evald AU - Vesterlund Thomas AU - Hansen Knud N. AU - Ravkilde Jan AU - Tilsted Hans-Henrik AU - Lassen Jens Flensted AU - Thuesen Leif VL - 7 IS - 3 Y1 - 29/07/2011 Y1 - 2011 DOI - 10.4244/EIJV7I3A56 SP - 323 EP - 331 KW - zotarolimus-eluting stent KW - sirolimus-eluting stent KW - diabetes PB - Europa Digital & Publishing SE - Clinical research UR - https://eurointervention.pcronline.com/article/late-lumen-loss-and-intima-hyperplasia-after-sirolimus-eluting-and-zotarolimus-eluting-stent-implantation-in-diabetic-patients-the-diabetes-and-drug-eluting-stent-diabedes-iii-angiography-and-intravascular-ultrasound-trial SN - 1774-024X ER -